NO983626L - Syntese av VIP-analog - Google Patents

Syntese av VIP-analog

Info

Publication number
NO983626L
NO983626L NO983626A NO983626A NO983626L NO 983626 L NO983626 L NO 983626L NO 983626 A NO983626 A NO 983626A NO 983626 A NO983626 A NO 983626A NO 983626 L NO983626 L NO 983626L
Authority
NO
Norway
Prior art keywords
synthesis
vip analog
analog
vip
relates
Prior art date
Application number
NO983626A
Other languages
English (en)
Other versions
NO983626D0 (no
Inventor
David Robert Bolin
Waleed Danho
Arthur M Felix
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of NO983626L publication Critical patent/NO983626L/no
Publication of NO983626D0 publication Critical patent/NO983626D0/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/57563—Vasoactive intestinal peptide [VIP]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Vascular Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Peptides Or Proteins (AREA)
  • Respiratory Apparatuses And Protective Means (AREA)
  • Regulating Braking Force (AREA)
  • Hydrogen, Water And Hydrids (AREA)
  • Catalysts (AREA)
  • Networks Using Active Elements (AREA)
  • Reduction Or Emphasis Of Bandwidth Of Signals (AREA)
NO983626A 1996-02-09 1998-08-07 Syntese av VIP-analog NO983626D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1142596P 1996-02-09 1996-02-09
PCT/EP1997/000380 WO1997029126A1 (en) 1996-02-09 1997-01-29 Synthesis of vip analog

Publications (2)

Publication Number Publication Date
NO983626L true NO983626L (no) 1998-08-07
NO983626D0 NO983626D0 (no) 1998-08-07

Family

ID=21750320

Family Applications (1)

Application Number Title Priority Date Filing Date
NO983626A NO983626D0 (no) 1996-02-09 1998-08-07 Syntese av VIP-analog

Country Status (15)

Country Link
US (2) US6080837A (no)
EP (1) EP0879246B1 (no)
JP (1) JP2000504676A (no)
KR (1) KR100493795B1 (no)
CN (1) CN1186355C (no)
AT (1) ATE328004T1 (no)
AU (1) AU722895B2 (no)
BR (1) BR9707409A (no)
CZ (1) CZ294779B6 (no)
DE (1) DE69735991D1 (no)
HU (1) HUP9900961A3 (no)
MX (1) MX9806099A (no)
NO (1) NO983626D0 (no)
NZ (1) NZ330885A (no)
WO (1) WO1997029126A1 (no)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE328004T1 (de) * 1996-02-09 2006-06-15 Hoffmann La Roche Herstellung eines vip-analogen
FR2775902B1 (fr) * 1998-03-13 2001-05-11 Assist Publ Hopitaux De Paris Utilisation d'analogues du vip dans la prevention et le traitement des lesions cerebrales du nouveau-ne humain
ES2245505T3 (es) * 1998-03-23 2006-01-01 Trimeris Inc. Metodos y composiciones para la sintesis de peptidos (t-20).
US6281331B1 (en) * 1998-03-23 2001-08-28 Trimeris, Inc. Methods and compositions for peptide synthesis
CN101229363A (zh) 2000-11-28 2008-07-30 蒙多生物技术许可股份公司 具有血管活性肠肽的生物学活性的用于治疗肺动脉和小动脉高压的化合物
US20060241028A1 (en) 2002-06-10 2006-10-26 Dorian Bevec Use of compounds having the biological activity of vasoactive intestinal peptide for the treatment of sarcoidosis
KR100451432B1 (ko) * 2002-07-12 2004-10-06 강충경 Ｔ-20 펩타이드의 생물학적 제조방법
WO2006023358A1 (en) * 2004-08-18 2006-03-02 Eli Lilly And Company Selective vpac2 receptor peptide agonists
US20080085860A1 (en) * 2004-08-18 2008-04-10 Eli Lilly And Company Selective Vpac2 Receptor Peptide Agonists
KR20090027239A (ko) * 2006-07-06 2009-03-16 에프. 호프만-라 로슈 아게 혈관작용성 장 펩티드의 유사체
ES2870914T3 (es) 2009-08-14 2021-10-28 Phasebio Pharmaceuticals Inc Péptidos intestinales vasoactivos modificados
CA2873553C (en) 2011-06-06 2020-01-28 Phasebio Pharmaceuticals, Inc. Use of modified vasoactive intestinal peptides in the treatment of hypertension
ES2822598T3 (es) 2015-02-09 2021-05-04 Phasebio Pharmaceuticals Inc Métodos y composiciones para tratar enfermedades y trastornos musculares
CN110317257B (zh) * 2019-06-03 2023-10-31 吉尔生化（上海）有限公司 一种辛卡利特的固液相合成法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4237046A (en) * 1979-04-27 1980-12-02 Miklos Bodanszky Polypeptides and methods of preparation
WO1991004041A1 (en) * 1989-09-15 1991-04-04 Rutgers, The State University Of New Jersey Process for inducing analgesia, peptides and therapeutic compositions
AU656230B2 (en) * 1991-10-11 1995-01-27 F. Hoffmann-La Roche Ag Cyclic vasoactive peptides
JPH0616694A (ja) * 1992-07-01 1994-01-25 Sato Seiyaku Kk カルシトニンの製造法
ES2051647B1 (es) * 1992-12-10 1995-01-16 Lipotec Sa Procedimiento para la preparacion de calcitonina de salmon.
ATE328004T1 (de) * 1996-02-09 2006-06-15 Hoffmann La Roche Herstellung eines vip-analogen

Also Published As

Publication number Publication date
EP0879246A1 (en) 1998-11-25
CZ294779B6 (cs) 2005-03-16
EP0879246B1 (en) 2006-05-31
CZ251698A3 (cs) 1998-11-11
KR19990082403A (ko) 1999-11-25
MX9806099A (es) 1998-10-31
DE69735991D1 (de) 2006-07-06
BR9707409A (pt) 1999-04-13
US6316593B1 (en) 2001-11-13
KR100493795B1 (ko) 2005-09-09
WO1997029126A1 (en) 1997-08-14
NZ330885A (en) 2000-02-28
CN1210543A (zh) 1999-03-10
AU722895B2 (en) 2000-08-10
JP2000504676A (ja) 2000-04-18
CN1186355C (zh) 2005-01-26
ATE328004T1 (de) 2006-06-15
US6080837A (en) 2000-06-27
HUP9900961A2 (hu) 1999-07-28
HUP9900961A3 (en) 2001-06-28
AU1596397A (en) 1997-08-28
NO983626D0 (no) 1998-08-07

Similar Documents

Publication Publication Date Title
NO983626D0 (no) Syntese av VIP-analog
DE69623996D1 (de) Hydrozyklon zur gastrennung
AUPP616498A0 (en) Synthesis of cyclic peptides
NO974378D0 (no) Fremgangsmåte til behandling av gasser
NO960497L (no) Dobbelt kolonneprosess for fjerning av nitrogen fra naturgass
DE69402043D1 (de) Verfahrenshilfsmittel für gaserzeugende Zusammensetzungen
NO20001310L (no) Separasjon av sure gasser fra naturgass
ZA966293B (en) Adsorptive separation of nitrogen from other gases.
NO20001315L (no) Separasjon av sure gasser fra gassblandinger
NO960911A (no) Anlegg for fremstilling av flytendegjort naturgass
DE69935313D1 (de) Nachweisverfahren für peptide
GB9607231D0 (en) Production of synthesis gas from hydrocarbonaceous feedstock
MX9801190A (es) Inhibidores de prolil endopeptidasa.
GB9523517D0 (en) Separation of gases
EP0831878A4 (en) NOVEL PEPTIDE INHIBITORS OF CALMODULIN
ZA961295B (en) Separation of gas mixtures
TR199600932T1 (tr) Yeni peptidlerin bagisiklik düzenleyici (immünomodülatör)etkileri.
BG103649A (en) Method for the preparation of eprosartan
NO943652D0 (no) Fremgangsmåte for fremstilling av 3-aminopyridiner fra 3-nitropyridiner
AU4095596A (en) Purification of natural gas
AU2061897A (en) Separation of calcium from metal compounds
IL118300A0 (en) Method for the purification of chlorine gas
ID18722A (id) Proses pemisahan ketoksim atau aldoksim dari amida
IL112349A (en) Separation of linear from branched hydrocarbons
GB9623773D0 (en) Mixtures of monoazopyridone gas

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application